Aesthetic pharmaceutical company Merz Aesthetics has announced the UK launch of the Ultherapy PRIME device.
According to the company, Ultherapy PRIME builds on the success of the original Ultherapy, using ultrasound technology and real-time imaging to provide lifting results by targeting skin laxity or loss of elasticity. The new PRIME device employs a sophisticated interface and more detailed imaging for more accurate results, according to Merz Aesthetics.
Gonzalo Mibelli, EMEA president at Merz Aesthetics, commented, “As one of the leaders in non-invasive lifting, we’re excited to bring Ultherapy PRIME to our customers as the next generation, premier platform of a proven technology and customisable, long-lasting treatment option.”
Merz Aesthetics is exhibiting at ACE 2025 at the Business Design Centre on March 14-15.
